Company Information

CORAL LABORATORIES LTD.

NSE : NABSE : 524506ISIN CODE : INE683E01017Industry : Pharmaceuticals & DrugsHouse : Private
BSE371.40-0.55 (-0.15 %)
PREV CLOSE ( ) 371.95
OPEN PRICE ( ) 371.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 814
TODAY'S LOW / HIGH ( )368.00 374.95
52 WK LOW / HIGH ( ) 225498.1
NSE
This Company is not listed in NSE
Non Executive DirectorSushma Kadkade
Rajendrasinh Rana
Non Executive Independent DirectorSheela Kamdar
Saurabh Shah
Malay Doshi
Whole Time DirectorGirish M Dhameja
Incorporation Year : 1997

Registered Office :

Address : 3 B Patanwala Compound,Opp. Shreyas Cinema,L B S Marg, Ghatkopar West Mumbai,
Maharashtra-400086 .

Phone :

Email :  accounts@corallab.com 

Industry : Pharmaceuticals & Drugs

Listing : BSE,Kolkata, Vadodara

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.